JetBlue Airways Corp. (Nasdaq: JBLU) announced plans to sell 20 million shares of common stock and $150 million in convertible debentures. Shares of the airliner dropped 74 cents to close at $4.29.
Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI) entered a license, distribution and supply agreement for Haemacure's proprietary fibrin and thrombin technology. The stock price climbed 34 cents to close at $1.89.
